Malabsorption as a Cause of Iron Treatment Failure in Infants

Not Applicable

Completed

• Conditions: Iron Deficiency; Malabsorption

• Registration Number: NCT00456729
• Lead Sponsor: HaEmek Medical Center, Israel

Brief Summary

Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment. The purpose of this study is to assess the incidence of malabsorption in those infants and to examine the results of empiric treatment with metronidazole.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-05
• Study Completion: 2006-07
• Status Verified: 2007-01
• Study First Submitted: 2007-04-04
• Study First Submitted QC: 2007-04-04
• Last Update Submitted: 2007-04-04
• Study First Posted: 2007-04-05
• Last Update Posted: 2007-04-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• All infants referred to the Pediatric Hematology Unit because lack of response to iron treatment.

Exclusion Criteria

• Patients diagnosed with specific malabsorption causes like Celiac or Cystic Fibrosis.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Hgb level

Secondary Outcome Measures

Name	Time	Method
Iron level
Ferritin Level

Trial Locations

Locations (1)

Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center; 🇮🇱 Afula, Israel